A Phase I Study of Continuous Oral Administration of SCH 66336 and 5-Fluorouracil/Leucovorin (5FU/LV) in Patients With Advanced Cancer
Phase of Trial: Phase I
Latest Information Update: 03 Apr 2013
At a glance
- Drugs Lonafarnib (Primary) ; Fluorouracil; Folinic acid
- Indications Cancer
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- 03 Apr 2013 Actual end date changed from Jan 2001 to Dec 2009 as reported by ClinicalTrials.gov.
- 17 Dec 2009 Actual end date (1 Jan 2001) added as reported by ClinicalTrials.gov.
- 17 Dec 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.